Literature DB >> 15637287

Mediation of basic fibroblast growth factor-induced lactotropic cell proliferation by Src-Ras-mitogen-activated protein kinase p44/42 signaling.

Kirti Chaturvedi1, Dipak K Sarkar.   

Abstract

Basic fibroblast growth factor (bFGF), which is secreted from folliculostellate cells in the anterior pituitary, is known to be involved in the communication between folliculostellate cells and lactotropes during estradiol-induced lactotropic cell proliferation. We studied the role of MAPK p44/42 in bFGF-regulated cell proliferation using enriched lactotropes and the lactotrope-derived PR1 cell line. In cell cultures, bFGF increased cell proliferation of PR1 cells and enriched lactotropes. In both of these cell populations, bFGF also increased phosphorylation of MAPK p44/42. U0126, an inhibitor of MAPK p44/42, blocked the bFGF-induced activation of MAPK p44/42 as well as the bFGF-induced cell proliferation of enriched lactotropes and PR1 cells. Treatment of PR1 cells with bFGF increased the activity of Ras p21, whereas overexpression of a dominant negative mutant of Ras p21 abrogated the bFGF-induced activation of MAPK p44/42 in these cells. Furthermore, the Src kinase inhibitor PP1 suppressed bFGF-induced activation of MAPK p44/42 in both enriched lactotropes and PR1 cells. The Src kinase inhibitor PP1 also reduced bFGF activation of Ras p21 and cell proliferation in PR1 cells. On the other hand, the bFGF-induced activation of MAPK p44/42 in enriched lactotropes and PR1 cells was not affected by protein kinase C inhibitors. These data suggest that bFGF induction of lactotropic cell proliferation is possibly mediated by activation of Src kinase, Ras p21, and MAPK p44/42.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637287      PMCID: PMC2869484          DOI: 10.1210/en.2004-1448

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  47 in total

1.  MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.

Authors:  J V Duncia; J B Santella; C A Higley; W J Pitts; J Wityak; W E Frietze; F W Rankin; J H Sun; R A Earl; A C Tabaka; C A Teleha; K F Blom; M F Favata; E J Manos; A J Daulerio; D A Stradley; K Horiuchi; R A Copeland; P A Scherle; J M Trzaskos; R L Magolda; G L Trainor; R R Wexler; F W Hobbs; R E Olson
Journal:  Bioorg Med Chem Lett       Date:  1998-10-20       Impact factor: 2.823

2.  Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells.

Authors:  J Szeberényi; H Cai; G M Cooper
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

Review 3.  Protein kinase C: structure, function, and regulation.

Authors:  A C Newton
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

Review 4.  The mitogen-activated protein kinase signal transduction pathway.

Authors:  R J Davis
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

5.  Protein kinase Cdelta mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells.

Authors:  K C Corbit; D A Foster; M R Rosner
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

Review 6.  Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity.

Authors:  C Liebmann
Journal:  Cell Signal       Date:  2001-11       Impact factor: 4.315

7.  A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions.

Authors:  G D'Arcangelo; S Halegoua
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Calcium influx induces neurite growth through a Src-Ras signaling cassette.

Authors:  G Rusanescu; H Qi; S M Thomas; J S Brugge; S Halegoua
Journal:  Neuron       Date:  1995-12       Impact factor: 17.173

9.  Hypertrophic effects of calcitonin gene-related peptide (CGRP) and amylin on adult mammalian ventricular cardiomyocytes.

Authors:  D Bell; K D Schlüter; X J Zhou; B J McDermott; H M Piper
Journal:  J Mol Cell Cardiol       Date:  1995-11       Impact factor: 5.000

10.  Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas.

Authors:  S Ezzat; H S Smyth; L Ramyar; S L Asa
Journal:  J Clin Endocrinol Metab       Date:  1995-03       Impact factor: 5.958

View more
  7 in total

1.  Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype.

Authors:  Allyson Booth; Tammy Trudeau; Crystal Gomez; M Scott Lucia; Arthur Gutierrez-Hartmann
Journal:  Mol Endocrinol       Date:  2014-12

2.  Isolation and characterization of rat pituitary endothelial cells.

Authors:  Kirti Chaturvedi; Dipak K Sarkar
Journal:  Neuroendocrinology       Date:  2006-10-04       Impact factor: 4.914

3.  Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.

Authors:  Jianping Xie; Adetola Olalekan Ajibade; Fengchun Ye; Kurt Kuhne; Shou-Jiang Gao
Journal:  Virology       Date:  2007-10-26       Impact factor: 3.616

Review 4.  Genesis of prolactinomas: studies using estrogen-treated animals.

Authors:  Dipak K Sarkar
Journal:  Front Horm Res       Date:  2006       Impact factor: 2.606

5.  Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures.

Authors:  Carlos Spuch; Yolanda Diz-Chaves; Diego Pérez-Tilve; Federico Mallo
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

6.  Fibroblast growth factor-2 autofeedback regulation in pituitary folliculostellate TtT/GF cells.

Authors:  George Vlotides; Yen-Hao Chen; Tamar Eigler; Song-Guang Ren; Shlomo Melmed
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

7.  Angiotensins inhibit cell growth in GH3 lactosomatotroph pituitary tumor cell culture: a possible involvement of the p44/42 and p38 MAPK pathways.

Authors:  Dorota Ptasinska-Wnuk; Hanna Lawnicka; Slawomir Mucha; Jolanta Kunert-Radek; Marek Pawlikowski; Henryk Stepien
Journal:  ScientificWorldJournal       Date:  2012-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.